Response to open letter on funding for Covid-19 therapy research
In an open letter in late September to the Federal Minister of Research as well as to the Federal Ministers of Health and Economic Affairs, BIO Deutschland called on funding not only for vaccine research, but also for the later stages of clinical development for promising drugs against Covid-19 to be initiated quickly. This would enable in particular severely ill patients to receive effective coronavirus therapies. BIO Deutschland has since received a response from the Federal Research Ministry. The response highlights the commitment to vaccine research, but does not indicate that there are plans to expand funding for Covid-19 therapy research.